HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sorin's Facil and Reply pacemakers approved in Japan

This article was originally published in Clinica

Executive Summary

The Japanese Ministry of Health, Labor and Welfare (MHLW) has approved the Facil and Reply pacemakers developed by Sorin. The dual- and single-chamber rate-responsive pacemakers are designed to prevent atrial fibrillation (AF). The Facil pacemaker is an 8cc device, and Reply offers the complete range of therapies in Facil with the addition of SafeR, an algorithm that allows the device to switch between atrial-based pacing and dual-chamber pacing modes. The Reply and Facil pacemakers will be distributed in Japan by Tokyo-based Japan Lifeline.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT043736

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel